Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by PG-Babyon May 13, 2015 8:43am

161 Views

Post# 23722938

Patients

As of May 12, 2015, 352 patients have been randomized into the EUPHRATES trial, 82 of whom have been randomized since implementation of the additional exclusion criterion in April, 2014.

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects